These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31000494)

  • 1. Reply to Vedang Murthy, Abhilash Gavarraju, and Rahul Krishnatry's Letter to the Editor re: Peter A.S. Johnstone, David Boulware, Rosa Djajadiningrat, et al. Primary Penile Cancer: The Role of Adjuvant Radiation Therapy in the Management of Extranodal Extension in Lymph Nodes. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2018.10.007.
    Johnstone PAS; Canter D; Spiess PE
    Eur Urol Focus; 2021 Jan; 7(1):226. PubMed ID: 31000494
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Peter A.S. Johnstone, David Boulware, Rosa Djajadiningrat, et al. Primary Penile Cancer: The Role of Adjuvant Radiation Therapy in the Management of Extranodal Extension in Lymph Nodes. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2018.10.007.
    Murthy V; Gavarraju A; Krishnatry R
    Eur Urol Focus; 2021 Jan; 7(1):225. PubMed ID: 30981672
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Sarah R. Ottenhof, Andrew Leone, Rosa S. Djajadiningrat, et al. Surgical and Oncological Outcomes in Patients After Vascularized Flap Reconstruction for Locoregionally Advanced Penile Cancer. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2018.02.002.
    Innocenti A; Melita D; Ghezzi S
    Eur Urol Focus; 2019 Nov; 5(6):1157. PubMed ID: 29674120
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Rodolfo Montironi, Marina Scarpelli, Alessia Cimadamore, and Gregor Mikuz's Letter to the Editor re: Theo van der Kwast, Fredrik Liedberg, Peter C. Black, et al. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.017. Focus on Our Personal Recollections and Observations.
    van der Kwast T; Van Rhijn B; Kamat A; Cheng L
    Eur Urol Focus; 2022 May; 8(3):885-886. PubMed ID: 33992577
    [No Abstract]   [Full Text] [Related]  

  • 5. Reply to Vikas Mishra's Letter to the Editor, re: Gregory W. Hosier, Thomas McGregor, Darren Beiko, et al. Persistent Opioid Use Among Patients with Urolithiasis: A Population based Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2019.08.011.
    Hosier GW; McGregor T; Beiko D; Jaeger M; Booth C; Whitehead M; Robert Siemens D
    Eur Urol Focus; 2021 Jul; 7(4):897. PubMed ID: 32327354
    [No Abstract]   [Full Text] [Related]  

  • 6. Reply to Carmen Gravina, Riccardo Lombardo, and Cosimo De Nunzio's Letter to the Editor re: Yash S. Khandwala, Simon John Christoph Soerensen, Shravan Morisetty, et al. The Association of Tissue Change and Treatment Success During High-intensity Focused Ultrasound Focal Therapy for Prostate Cancer. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.10.010.
    Sonn G; Khandwala Y
    Eur Urol Focus; 2023 Sep; 9(5):822-823. PubMed ID: 37012086
    [No Abstract]   [Full Text] [Related]  

  • 7. Reply to Giorgio Gandaglia, Alberto Briganti, Daniele Raggi, et al's Letter to the Editor re: Philipp Mandel, Benedikt Hoeh, Mike Wenzel, et al. Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2022.08.007.
    Hoeh B; Chun FKH; Mandel P
    Eur Urol Focus; 2023 Feb; ():. PubMed ID: 36813619
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Eugenio Ventimiglia, Steeve Doizi, Andrea Salonia, and Olivier Traxer's Letter to the Editor re: Farha Pirani, Salima S. Makhani, Frances Y. Kim, et al. Prospective Randomized Trial Comparing the Safety and Clarity of Water Versus Saline Irrigant in Ureteroscopy. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.02.009.
    Pirani F; Makhani S; Kim F; Lay A; Cimmino C; Hartsell L; Spence A; Master VA; Ogan K
    Eur Urol Focus; 2021 May; 7(3):666-667. PubMed ID: 32536594
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary Penile Cancer: The Role of Adjuvant Radiation Therapy in the Management of Extranodal Extension in Lymph Nodes.
    Johnstone PAS; Boulware D; Djajadiningrat R; Ottenhof S; Necchi A; Catanzaro M; Ye D; Zhu Y; Nicolai N; Horenblas S; Spiess PE
    Eur Urol Focus; 2019 Sep; 5(5):737-741. PubMed ID: 30327282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to Luca Sarchi, Maria Chiara Sighinolfi, Simone Assumma, et al.'s Letter to Editor re: Carlo A. Bravi, Marco Paciotti, Eleonora Balestrazzi, et al. Outcomes of Robot-assisted Radical Prostatectomy with the Hugo RAS Surgical System: Initial Experience at a High-volume Robotic Center. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.01.008.
    Bravi CA; Mottrie A
    Eur Urol Focus; 2023 Sep; 9(5):843. PubMed ID: 36898944
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Antonio Andrea Grosso, Agostino Tuccio, Matteo Salvi, Daniele Paganelli, Andrea Minervini, and Fabrizio Di Maida's Letter to the Editor re: Paolo Capogrosso, Eugenio Ventimiglia, Giuseppe Fallara, et al. Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve. Eur Urol Focus 2023;9:813-21. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.05.013.
    Lin YH; Chen ST; Juang HH
    Eur Urol Focus; 2024 Jan; ():. PubMed ID: 38272718
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Shun Wan, Kun-peng Li, and Li Yang's Letter to the Editor re: Jordan M. Rich, Kennedy E. Okhawere, Charles Nguyen, et al. Transperitoneal Versus Retroperitoneal Single-port Robotic-assisted Partial Nephrectomy: An Analysis from the Single Port Advanced Research Consortium. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.06.004.
    Rich JM; Okhawere KE; Razdan S; Badani KK
    Eur Urol Focus; 2023 Sep; ():. PubMed ID: 37739915
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Hsiao-Chun Chang and Shiu-Dong Chung's Letter to the Editor re: Britta Grüne, F abian Siegel, Frank Waldbillig, et al. Long-term Reinterventions after Thulium Laser Enucleation of the Prostate: 12-Year Experience with more than 1000 Patients. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.12.006.
    Grüne B; von Hardenberg J
    Eur Urol Focus; 2022 Nov; 8(6):1866. PubMed ID: 35307320
    [No Abstract]   [Full Text] [Related]  

  • 14. Reply to Eleonora Rosato, Riccardo Lombardo, Vincenzo Li Marzi, Enrico Finazzi Agrò, Cosimo De Nunzio, and Simone Albisinni's Letter to the Editor re: Rano Matta, Refik Saskin, Sarah Neu, et al. Predicting Mirabegron Treatment Response in Patients with Overactive Bladder: A Post Hoc Analysis of Data from Clinical Trials. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.04.001.
    Matta R
    Eur Urol Focus; 2023 Oct; ():. PubMed ID: 37858406
    [No Abstract]   [Full Text] [Related]  

  • 15. Reply to Nikolaos Grivas, Sanchia Goonewardene, Wouter Everaerts, Nikolaos Kalampokis's Letter to the Editor re: Andrea Mari, Riccardo Tellini, Francesco Porpiglia, et al. Perioperative and Mid-term Oncological and Functional Outcomes After Partial Nephrectomy for Complex (PADUA Score ≥10) Renal Tumors: A Prospective Multicenter Observational Study (the RECORD2, Project). Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2020.07.004.
    Mari A; Tellini R; Ficarra V; Carini M; Minervini A;
    Eur Urol Focus; 2021 Sep; 7(5):1212-1213. PubMed ID: 33384273
    [No Abstract]   [Full Text] [Related]  

  • 16. Reply to Carmen Gravina, Riccardo Lombardo, and Cosimo De Nunzio's Letter to the Editor re: Georges Mjaess, Alexandre Peltier, Jean-Baptiste Roche, et al. A Novel Nomogram to Identify Candidates for Focal Therapy Among Patients with Localized Prostate Cancer Diagnosed via Magnetic Resonance Imaging-Targeted and Systematic Biopsies: A European Multicenter Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.04.008.
    Mjaess G; Roumeguère T; Diamand R
    Eur Urol Focus; 2024 Jan; 10(1):75-76. PubMed ID: 37543515
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to Francesco Montorsi, Alessandro Larcher, and Umberto Capitanio's Letter to the Editor re: Rohann J.M. Correa, Alexander V. Louie, Nicholas G. Zaorsky, et al. The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Eur Urol Focus. 2019 Jun 24. pii: S2405-4569(19)30157-9. https://doi.org/10.1016/j.euf.2019.06.002. [Epub ahead of print].
    Correa RJM; Louie AV; Zaorsky NG; Lehrer EJ; Ellis R; Ponsky L; Kaplan I; Mahadevan A; Chu W; Swaminath A; Hannan R; Onishi H; Teh BS; Muacevic A; Lo SS; Staehler M; Siva S
    Eur Urol Focus; 2021 Mar; 7(2):404-405. PubMed ID: 31679868
    [No Abstract]   [Full Text] [Related]  

  • 18. Reply to Nikolaos Grivas and Henk G. van der Poel's Letter to the Editor re: Rui Farinha, Giuseppe Rosiello, Artur De Oliveira Paludo, et al. Selective Suturing or Sutureless Technique in Robot-assisted Partial Nephrectomy: Results from a Propensity-score Matched Analysis. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.019.
    Farinha R; Rosiello G; Puliatti S; Mottrie A
    Eur Urol Focus; 2022 May; 8(3):888-889. PubMed ID: 34031018
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Theo van der Kwast, Fredrik Liedberg, Peter C. Black, et al. International Society of Urological Pathology Expert Opinion on Grading of Urothelial Carcinoma. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.03.017: Focus on Our Personal Recollections and Observations.
    Montironi R; Scarpelli M; Cimadamore A; Mikuz G
    Eur Urol Focus; 2022 May; 8(3):882-884. PubMed ID: 33994166
    [No Abstract]   [Full Text] [Related]  

  • 20. Reply to Marco Moschini, Francesco Montorsi, Andrea Salonia, Giorgio Gandaglia and Alberto Briganti's Letter to the Editor Re: Francesco Soria, Matteo Rosazza, Simone Livoti, et al. Repeat Transurethral Resection (TUR) + Bacillus Calmette-Guérin (BCG) Versus Upfront Induction BCG After TUR in High-risk Non-muscle-invasive Bladder Cancer: Feasibility Phase of a Randomized Controlled Study. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2023.10.019.
    Soria F; Gontero P
    Eur Urol Focus; 2024 Jan; ():. PubMed ID: 38278711
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.